I totally agree. This is the closest thing ever to an obviously undervalued stock with such huge upside potential which is based on clinical research and a large patent portfolio.
Firstly you do not know the ground rules regarding the FDA. Let them address it. Secondly, XXII is getting into the ring with Big Tobacco which has lots of friends in Congress and plenty of money and lawyers. This company will do very well but I would say the FDA mandate will be a 3-5 year process. You see Phillip Morris does not grow tobacco. They buy it and process it..make Marlboros taste like Marlboros with some flavoring but they can't take away the nicotine. If the FDA is serious then every manufacturer will have to come see us. We will get a better feel when the company speaks to us, but Rome wasn't built in a day and the best way to play this stock is just own it and go away. Too many trading types got involved and now they are losing money.
News 
Market Data 
Discover 
